- Assessment of total tau protein, phospho-tau and beta amyloid in cerebrospinal fluid: the first experience of our laboratory2004 | Second Faculty of Medicine
- The role of proportion of cerebroepinal fluid total tau-protein levels to phosphorylated tau protein levels in differential of Demencia +12008 | Faculty of Medicine in Hradec Králové
- The role of proportion of cerebroepinal fluid total tau-protein levels to phosphorylated tau protein levels in differential of Demencia2008 | First Faculty of Medicine
- The liquor tau protein and beta amylold in Alzheimer's disease2007 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Proportion of tau protein to phosphorylated tau protein CSF levels in differential diagnosis of dementia2008 | Second Faculty of Medicine
- Tau protein, phosphorylated tau protein, and beta-amyloid 42 levels in patients with neurodegenerative diseases complicated by cognitive deficits A non-randomized, concurrent, case-control investigation2009 | Second Faculty of Medicine
- Total and Phosphorylated Tau-protein and Beta-Amyloid 42 in Cerebrospinal Fluid in Dementias and Multiple Sclerosis2008 | Faculty of Medicine in Hradec Králové
- Total and Phosphorylated Tau-protein and Beta-Amyloid 42 in Cerebrospinal Fluid in Dementias and Multiple Sclerosis2008 | First Faculty of Medicine
- Overview of Immunoanalytical Methods for Determination of Alzheimer's Disease Biomarkers' Triplet in Cerebrospinal Fluid and Blood2020 | First Faculty of Medicine, Third Faculty of Medicine
- Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators2022 | First Faculty of Medicine
- Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases2015 | First Faculty of Medicine, Third Faculty of Medicine
- Tau protein determination in cerebrospinal fluid in patients with multiple sclerosis by two ELISA kits2011 | First Faculty of Medicine, Third Faculty of Medicine
- Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe2010 | Third Faculty of Medicine, Second Faculty of Medicine
- Charles Bonnet syndrome as the first sign of Alzheimer's disease2006 | First Faculty of Medicine, Second Faculty of Medicine
- Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid2022 | Second Faculty of Medicine
- Cerebrospinal Fluid Triplet in the Diagnosis of Alzheimer-Fischer disease2012 | Third Faculty of Medicine
- The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers?2019 | First Faculty of Medicine
- Genetic Creutzfeldt-Jakob disease with R208H mutation presenting as progressive supranuclear palsy2012 | Third Faculty of Medicine, Central Library of Charles University
- Neuroinflammation and Complexes of 17 beta-Hydroxysteroid Dehydrogenase type 10-Amyloid beta in Alzheimer's Disease2013 | Third Faculty of Medicine, Central Library of Charles University
- Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up2021 | First Faculty of Medicine, Third Faculty of Medicine
- Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation2017 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity2020 | Second Faculty of Medicine
- Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis2021 | Third Faculty of Medicine
- Metastatic intracranial spread of adenocarcinoma mimicking Creutzfeldt-Jakob disease in two cases2021 | First Faculty of Medicine, Third Faculty of Medicine
- The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies2020 | Second Faculty of Medicine
- Different Profiles of Spatial Navigation Deficits In Alzheimer's Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment2022 | Second Faculty of Medicine